These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 22572996)

  • 61. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
    Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome.
    Hamed HO
    J Obstet Gynaecol Res; 2013 Dec; 39(12):1596-603. PubMed ID: 23875783
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of LH and high-density lipoprotein cholesterol (HDL-C) on metformin response in women with polycystic ovary syndrome.
    Maciel GA; Hayashida SA; da Costa LC; Marcondes JA; da Fonseca AM; Soares JM; Baracat EC
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):180-4. PubMed ID: 21530060
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
    Horng SG; Wang TH; Wang HS
    Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
    Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.
    Seow KM; Juan CC; Ho LT; Hsu YP; Lin YH; Huang LW; Hwang JL
    Hum Reprod; 2007 Apr; 22(4):1100-6. PubMed ID: 17208941
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR‑223/GLUT4 and SNHG20/miR‑4486/GLUT4 signaling.
    Liu J; Zhao Y; Chen L; Li R; Ning Y; Zhu X
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35552758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
    Kilic S; Yilmaz N; Zulfikaroglu E; Erdogan G; Aydin M; Batioglu S
    Gynecol Endocrinol; 2011 Sep; 27(9):622-9. PubMed ID: 21105835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome.
    Tan BK; Chen J; Hu J; Amar O; Mattu HS; Adya R; Patel V; Ramanjaneya M; Lehnert H; Randeva HS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1891-900. PubMed ID: 24152681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of metformin treatment on endometrial vascular indices in anovulatory obese/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography.
    Mohsen IA; Elkattan E; Nabil H; Khattab S
    J Clin Ultrasound; 2013 Jun; 41(5):275-82. PubMed ID: 23124626
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome.
    Iwata MC; Porquere L; Sorpreso IC; Baracat EC; Soares Júnior JM
    Rev Assoc Med Bras (1992); 2015; 61(3):215-9. PubMed ID: 26248242
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Circulating ghrelin levels in patients with polycystic ovary syndrome.
    Schöfl C; Horn R; Schill T; Schlösser HW; Müller MJ; Brabant G
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4607-10. PubMed ID: 12364442
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
    J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
    Pagotto U; Gambineri A; Vicennati V; Heiman ML; Tschöp M; Pasquali R
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5625-9. PubMed ID: 12466363
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
    Kashani L; Omidvar T; Farazmand B; Modabbernia A; Ramzanzadeh F; Tehraninejad ES; Ashrafi M; Tabrizi M; Akhondzadeh S
    Psychoneuroendocrinology; 2013 Jun; 38(6):767-76. PubMed ID: 22999261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome--a proof-of-concept study.
    Shafiee MN; Malik DA; Yunos RI; Atiomo W; Omar MH; Ghani NA; Hatta AZ; Seedhouse C; Chapman C; Mokhtar NM
    Gynecol Endocrinol; 2015 Apr; 31(4):286-90. PubMed ID: 25495168
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.
    Baillargeon JP; Iuorno MJ; Jakubowicz DJ; Apridonidze T; He N; Nestler JE
    J Clin Endocrinol Metab; 2004 Jan; 89(1):242-9. PubMed ID: 14715857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.